Skip to content
2000
image of Study Integrating GWAS and pQTL Data Identifies Potential Therapeutic Targets for Hypertension

Abstract

Background

Hypertension, a major risk factor for cardiovascular disease morbidity and mortality, remains poorly controlled in many patients despite available treatments. There are many patients with poorly managed blood pressure despite the availability of treatments. We employed Mendelian Randomization (MR) and colocalization analyses of plasma proteins and hypertension to identify genetically supported drug targets.

Methods

We investigated genetic associations between plasma protein quantitative trait loci (pQTLs) and hypertension GWAS data from FinnGen using two-sample MR, enrichment analysis, and Protein-Protein Interaction (PPI) analysis. Colocalization verified shared causal variants between identified proteins and hypertension. Drug prediction and molecular docking were used to assess therapeutic potential.

Results

In the MR analysis, 12 plasma proteins were found to be associated with hypertension, three of which (ACE, AGT, and NPPA) were supported by colocalization. Among these, ACE and AGT are established drug targets, whereas NPPA remains relatively underexplored. Drug prediction and molecular docking results indicated that several candidate drugs exhibited highly stable interactions and strong binding affinities with the screened proteins.

Discussion

Our findings confirm the centrality of the renin-angiotensin system (ACE, AGT) and highlight NPPA as a novel, genetically supported protective target. While the study benefits from robust MR and colocalization methods, the focus on European ancestry warrants validation in diverse populations. Experimental and clinical studies are needed to translate these targets into therapies.

Conclusion

This proteome-wide MR analysis demonstrates a causal relationship between genetically determined levels of ACE, AGT, and NPPA and hypertension. These proteins represent promising targets for the development of novel hypertension therapeutics.

This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cad/10.2174/0115734099382081251126112854
2026-01-12
2026-01-19
Loading full text...

Full text loading...

/deliver/fulltext/cad/10.2174/0115734099382081251126112854/BMS-CCADD-2024-HT21-6752-2.html?itemId=/content/journals/cad/10.2174/0115734099382081251126112854&mimeType=html&fmt=ahah

References

  1. Zhou B. Perel P. Mensah G.A. Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat. Rev. Cardiol. 2021 18 11 785 802 10.1038/s41569‑021‑00559‑8 34050340
    [Google Scholar]
  2. Geldsetzer P. Manne-Goehler J. Marcus M.E. Ebert C. Zhumadilov Z. Wesseh C.S. Tsabedze L. Supiyev A. Sturua L. Bahendeka S.K. Sibai A.M. Quesnel-Crooks S. Norov B. Mwangi K.J. Mwalim O. Wong-McClure R. Mayige M.T. Martins J.S. Lunet N. Labadarios D. Karki K.B. Kagaruki G.B. Jorgensen J.M.A. Hwalla N.C. Houinato D. Houehanou C. Msaidié M. Guwatudde D. Gurung M.S. Gathecha G. Dorobantu M. Damasceno A. Bovet P. Bicaba B.W. Aryal K.K. Andall-Brereton G. Agoudavi K. Stokes A. Davies J.I. Bärnighausen T. Atun R. Vollmer S. Jaacks L.M. The state of hypertension care in 44 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet 2019 394 10199 652 662 10.1016/S0140‑6736(19)30955‑9 31327566
    [Google Scholar]
  3. Zhou B. Danaei G. Stevens G.A. Bixby H. Taddei C. Carrillo-Larco R.M. Solomon B. Riley L.M. Di Cesare M. Iurilli M.L.C. Rodriguez-Martinez A. Zhu A. Hajifathalian K. Amuzu A. Banegas J.R. Bennett J.E. Cameron C. Cho Y. Clarke J. Craig C.L. Cruz J.J. Gates L. Giampaoli S. Gregg E.W. Hardy R. Hayes A.J. Ikeda N. Jackson R.T. Jennings G. Joffres M. Khang Y-H. Koskinen S. Kuh D. Kujala U.M. Laatikainen T. Lehtimäki T. Lopez-Garcia E. Lundqvist A. Maggi S. Magliano D.J. Mann J.I. McLean R.M. McLean S.B. Miller J.C. Morgan K. Neuhauser H.K. Niiranen T.J. Noale M. Oh K. Palmieri L. Panza F. Parnell W.R. Peltonen M. Raitakari O. Rodríguez-Artalejo F. Roy J.G.R. Salomaa V. Sarganas G. Servais J. Shaw J.E. Shibuya K. Solfrizzi V. Stavreski B. Tan E.J. Turley M.L. Vanuzzo D. Viikari-Juntura E. Weerasekera D. Ezzati M. NCD Risk Factor Collaboration (NCD-RisC).Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: An analysis of 123 nationally representative surveys. Lancet 2019 394 10199 639 651 10.1016/S0140‑6736(19)31145‑6 31327564
    [Google Scholar]
  4. Attaei M.W. Khatib R. McKee M. Lear S. Dagenais G. Igumbor E.U. AlHabib K.F. Kaur M. Kruger L. Teo K. Lanas F. Yusoff K. Oguz A. Gupta R. Yusufali A.M. Bahonar A. Kutty R. Rosengren A. Mohan V. Avezum A. Yusuf R. Szuba A. Rangarajan S. Chow C. Yusuf S. Yusuf S. Rangarajan S. Teo K.K. Chow C.K. O’Donnell M. Mente A. Leong D. Smyth A. Joseph P. Islam S. Zhang M. Hu W. Ramasundarahettige C. Wong G. Dayal L. Casanova A. Dehghan M. Lewis G. Aliberti A. Reyes A. Zaki A. Lewis B. Zhang B. Agapay D. Hari D. Milazzo E. Ramezani E. Hussain F. Shifaly F. Kay I. Rimac J. Swallow J. Heldman L. Mushtaha M. Mushtaha M. Trottier M. Aoucheva N. Kandy N. Mackie P. Solano R. Chin S. Ramacham S. Shahrook S. Trottier S. Tongana T. ElSheikh W. Lindeman J. McQueen M. Hall K. Keys J. Wang X. Keneth J. Devanath A. Diaz R. Orlandini A. Linetsky B. Toscanelli S. Casaccia G. Maini Cuneo J.M. Rahman O. Yusuf R. Azad A.K. Rabbani K.A. Cherry H.M. Mannan A. Hassan I. Talukdar A.T. Tooheen R.B. Khan M.U. Sintaha M. Choudhury T. Haque R. Parvin S. Avezum A. Oliveira G.B. Marcilio C.S. Mattos A.C. Teo K. Yusuf S. Dejesus J. Agapay D. Tongana T. Solano R. Kay I. Trottier S. Rimac J. Elsheikh W. Heldman L. Ramezani E. Dagenais G. Poirier P. Turbide G. Auger D. De Bluts A.L.B. Proulx M.C. Cayer M. Bonneville N. Lear S. Gasevic D. Corber E. de Jong V. Vukmirovich I. Wielgosz A. Fodor G. Pipe A. Shane A. Lanas F. Seron P. Martinez S. Valdebenito A. Oliveros M. Wei L. Lisheng L. Chunming C. Xingyu W. Wenhua Z. Hongye Z. JiaXuan; Bo, H.; Yi, S.; Jian, B.; Xiuwen, Z.; Xiaohong, C.; Tao, C.; Hui, C.; Xiaohong, C.; Qing, D.; Xiaoru, C.; Qing, D.; Xinye, H.; Bo, H.; JiaXuan; Jian, L.; Juan, L.; Xu, L.; Bing, R.; Yi, S.; Wei, W.; Yang, W.; Jun, Y.; Yi, Z.; Hongye, Z.; Xiuwen, Z.; Manlu, Z.; Fanghong, L.; Jianfang, W.; Yindong, L.; Yan, H.; Liangqing, Z.; Baoxia, G.; Xiaoyang, L.; Shiying, Z.; BianRongwen; TianXiuzhen; Dong, L.; Di, C.; Jianguo, W.; Yize, X.; Tianlu, L.; Peng, Z.; Changlin, D.; Ning, L.; Xiaolan, M.; Yuqing, Y.; Rensheng, L.; Minfan, F.; Jing, H.; Yu, L.; Xiaojie, X.; Qiang, Z.; Lopez-Jaramillo, P.; Lopez, P.A.C.; Garcia, R.; Jurado, L.J.A.; Gómez-Arbeláez, D.; Arguello, J.F.; Dueñas, R.; Silva, S.; Pradilla, L.P.; Ramirez, F.; Molina, D.I.; Cure-Cure, C.; Perez, M.; Hernandez, E.; Arcos, E.; Fernandez, S.; Narvaez, C.; Paez, J.; Sotomayor, A.; Garcia, H.; Sanchez, G.; David, T.; Rico, A.; Mony, P.; Vaz, M.; Bharathi, A.V.; Swaminathan, S.; Shankar, K.; Kurpad, A.V.; Jayachitra, K.G.; Kumar, N.; Hospital, H.A.L.; Mohan, V.; Deepa, M.; Parthiban, K.; Anitha, M.; Hemavathy, S.; Rahulashankiruthiyayan, T.; Anitha, D.; Sridevi, K.; Gupta, R.; Panwar, R.B.; Mohan, I.; Rastogi, P.; Rastogi, S.; Bhargava, R.; Kumar, R.; Thakur, J.S.; Patro, B.; Lakshmi, P.V.M.; Mahajan, R.; Chaudary, P.; Kutty, V.R.; Vijayakumar, K.; Ajayan, K.; Rajasree, G.; Renjini, A.R.; Deepu, A.; Sandhya, B.; Asha, S.; Soumya, H.S.; Kelishadi, R.; Bahonar, A.; Mohammadifard, N.; Heidari, H.; Yusoff, K.; Ismail, T.S.T.; Ng, K.K.; Devi, A.; Nasir, N.M.; Yasin, M.M.; Miskan, M.; Rahman, E.A.; Arsad, M.K.M.; Ariffin, F.; Razak, S.A.; Majid, F.A.; Bakar, N.A.; Yacob, M.Y.; Zainon, N.; Salleh, R.; Ramli, M.K.A.; Halim, N.A.; Norlizan, S.R.; Ghazali, N.M.; Arshad, M.N.; Razali, R.; Ali, S.; Othman, H.R.; Hafar, C.W.J.C.W.; Pit, A.; Danuri, N.; Basir, F.; Zahari, S.N.A.; Abdullah, H.; Arippin, M.A.; Zakaria, N.A.; Noorhassim, I.; Hasni, M.J.; Azmi, M.T.; Zaleha, M.I.; Hazdi, K.Y.; Rizam, A.R.; Sazman, W.; Azman, A.; Khatib, R.; Khammash, U.; Khatib, A.; Giacaman, R.; Iqbal, R.; Afridi, A.; Khawaja, R.; Raza, A.; Kazmi, K.; Dans, A.; Co, H.U.; Sanchez, J.T.; Pudol, L.; Zamora-Pudol, C.; Palileo-Villanueva, L.A.M.; Aquino, M.R.; Abaquin, C.; Pudol, S.L.; Cabral, M.L.; Zatonski, W.; Szuba, A.; Zatonska, K.; Ilow, R.; Ferus, M.; Regulska-Ilow, B.; Różańska, D.; Wolyniec, M.; AlHabib, K.F.; Hersi, A.; Kashour, T.; Alfaleh, H.; Alshamiri, M.; Altaradi, H.B.; Alnobani, O.; Bafart, A.; Alkamel, N.; Ali, M.; Abdulrahman, M.; Nouri, R.; Kruger, A.; Voster, H.H.; Schutte, A.E.; Wentzel-Viljoen, E.; Eloff, F.C.; de Ridder, H.; Moss, H.; Potgieter, J.; Roux, A.A.; Watson, M.; de Wet, G.; Olckers, A.; Jerling, J.C.; Pieters, M.; Hoekstra, T.; Puoane, T.; Igumbor, E.; Tsolekile, L.; Sanders, D.; Naidoo, P.; Steyn, N.; Peer, N.; Mayosi, B.; Rayner, B.; Lambert, V.; Levitt, N.; Kolbe-Alexander, T.; Ntyintyane, L.; Hughes, G.; Swart, R.; Fourie, J.; Muzigaba, M.; Xapa, S.; Gobile, N.; Ndayi, K.; Jwili, B.; Ndibaza, K.; Egbujie, B.; Rosengren, A.; Boström, K.B.; Lindblad, U.; Langkilde, P.; Gustavsson, A.; Andreasson, M.; Snällman, M.; Wirdemann, L.; Pettersson, K.; Moberg, E.; Yeates, K.; Sleeth, J.; Kilonzo, K.; Oguz, A.; Akalin, A.A.K.; Calik, K.B.T.; Imeryuz, N.; Temizhan, A.; Alphan, E.; Gunes, E.; Sur, H.; Karsidag, K.; Gulec, S.; Altuntas, Y.; Yusufali, A.M.; Almahmeed, W.; Swidan, H.; Darwish, E.A.; Hashemi, A.R.A.; Al-Khaja, N.; Muscat-Baron, J.M.; Ahmed, S.H.; Mamdouh, T.M.; Darwish, W.M.; Abdelmotagali, M.H.S.; Awed, S.A.O.; Movahedi, G.A.; Hussain, F.; Shaibani, H.A.; Gharabou, R.I.M.; Youssef, D.F.; Nawati, A.Z.S.; Salah, Z.A.R.A.; Abdalla, R.F.E.; Shuwaihi, S.M.A.; Omairi, M.A.A.; Cadigal, O.D.; Alejandrino, R.S.; Chifamba, J.; Gwaunza, L.; Terera, G.; Mahachi, C.; Murambiwa, P.; Machiweni, T.; Mapanga, R. PURE study investigators. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health 2017 2 9 e411 e419 10.1016/S2468‑2667(17)30141‑X 29253412
    [Google Scholar]
  5. Padmanabhan S. Dominiczak A.F. Genomics of hypertension: The road to precision medicine. Nat. Rev. Cardiol. 2021 18 4 235 250 10.1038/s41569‑020‑00466‑4 33219353
    [Google Scholar]
  6. Evangelou E. Warren H.R. Mosen-Ansorena D. Mifsud B. Pazoki R. Gao H. Ntritsos G. Dimou N. Cabrera C.P. Karaman I. Ng F.L. Evangelou M. Witkowska K. Tzanis E. Hellwege J.N. Giri A. Velez Edwards D.R. Sun Y.V. Cho K. Gaziano J.M. Wilson P.W.F. Tsao P.S. Kovesdy C.P. Esko T. Mägi R. Milani L. Almgren P. Boutin T. Debette S. Ding J. Giulianini F. Holliday E.G. Jackson A.U. Li-Gao R. Lin W.Y. Luan J. Mangino M. Oldmeadow C. Prins B.P. Qian Y. Sargurupremraj M. Shah N. Surendran P. Thériault S. Verweij N. Willems S.M. Zhao J.H. Amouyel P. Connell J. de Mutsert R. Doney A.S.F. Farrall M. Menni C. Morris A.D. Noordam R. Paré G. Poulter N.R. Shields D.C. Stanton A. Thom S. Abecasis G. Amin N. Arking D.E. Ayers K.L. Barbieri C.M. Batini C. Bis J.C. Blake T. Bochud M. Boehnke M. Boerwinkle E. Boomsma D.I. Bottinger E.P. Braund P.S. Brumat M. Campbell A. Campbell H. Chakravarti A. Chambers J.C. Chauhan G. Ciullo M. Cocca M. Collins F. Cordell H.J. Davies G. de Borst M.H. de Geus E.J. Deary I.J. Deelen J. Del Greco M. F.; Demirkale, C.Y.; Dörr, M.; Ehret, G.B.; Elosua, R.; Enroth, S.; Erzurumluoglu, A.M.; Ferreira, T.; Frånberg, M.; Franco, O.H.; Gandin, I.; Gasparini, P.; Giedraitis, V.; Gieger, C.; Girotto, G.; Goel, A.; Gow, A.J.; Gudnason, V.; Guo, X.; Gyllensten, U.; Hamsten, A.; Harris, T.B.; Harris, S.E.; Hartman, C.A.; Havulinna, A.S.; Hicks, A.A.; Hofer, E.; Hofman, A.; Hottenga, J.J.; Huffman, J.E.; Hwang, S.J.; Ingelsson, E.; James, A.; Jansen, R.; Jarvelin, M.R.; Joehanes, R.; Johansson, Å.; Johnson, A.D.; Joshi, P.K.; Jousilahti, P.; Jukema, J.W.; Jula, A.; Kähönen, M.; Kathiresan, S.; Keavney, B.D.; Khaw, K.T.; Knekt, P.; Knight, J.; Kolcic, I.; Kooner, J.S.; Koskinen, S.; Kristiansson, K.; Kutalik, Z.; Laan, M.; Larson, M.; Launer, L.J.; Lehne, B.; Lehtimäki, T.; Liewald, D.C.M.; Lin, L.; Lind, L.; Lindgren, C.M.; Liu, Y.; Loos, R.J.F.; Lopez, L.M.; Lu, Y.; Lyytikäinen, L.P.; Mahajan, A.; Mamasoula, C.; Marrugat, J.; Marten, J.; Milaneschi, Y.; Morgan, A.; Morris, A.P.; Morrison, A.C.; Munson, P.J.; Nalls, M.A.; Nandakumar, P.; Nelson, C.P.; Niiranen, T.; Nolte, I.M.; Nutile, T.; Oldehinkel, A.J.; Oostra, B.A.; O’Reilly, P.F.; Org, E.; Padmanabhan, S.; Palmas, W.; Palotie, A.; Pattie, A.; Penninx, B.W.J.H.; Perola, M.; Peters, A.; Polasek, O.; Pramstaller, P.P.; Nguyen, Q.T.; Raitakari, O.T.; Ren, M.; Rettig, R.; Rice, K.; Ridker, P.M.; Ried, J.S.; Riese, H.; Ripatti, S.; Robino, A.; Rose, L.M.; Rotter, J.I.; Rudan, I.; Ruggiero, D.; Saba, Y.; Sala, C.F.; Salomaa, V.; Samani, N.J.; Sarin, A.P.; Schmidt, R.; Schmidt, H.; Shrine, N.; Siscovick, D.; Smith, A.V.; Snieder, H.; Sõber, S.; Sorice, R.; Starr, J.M.; Stott, D.J.; Strachan, D.P.; Strawbridge, R.J.; Sundström, J.; Swertz, M.A.; Taylor, K.D.; Teumer, A.; Tobin, M.D.; Tomaszewski, M.; Toniolo, D.; Traglia, M.; Trompet, S.; Tuomilehto, J.; Tzourio, C.; Uitterlinden, A.G.; Vaez, A.; van der Most, P.J.; van Duijn, C.M.; Vergnaud, A.C.; Verwoert, G.C.; Vitart, V.; Völker, U.; Vollenweider, P.; Vuckovic, D.; Watkins, H.; Wild, S.H.; Willemsen, G.; Wilson, J.F.; Wright, A.F.; Yao, J.; Zemunik, T.; Zhang, W.; Attia, J.R.; Butterworth, A.S.; Chasman, D.I.; Conen, D.; Cucca, F.; Danesh, J.; Hayward, C.; Howson, J.M.M.; Laakso, M.; Lakatta, E.G.; Langenberg, C.; Melander, O.; Mook-Kanamori, D.O.; Palmer, C.N.A.; Risch, L.; Scott, R.A.; Scott, R.J.; Sever, P.; Spector, T.D.; van der Harst, P.; Wareham, N.J.; Zeggini, E.; Levy, D.; Munroe, P.B.; Newton-Cheh, C.; Brown, M.J.; Metspalu, A.; Hung, A.M.; O’Donnell, C.J.; Edwards, T.L.; Psaty, B.M.; Tzoulaki, I.; Barnes, M.R.; Wain, L.V.; Elliott, P.; Caulfield, M.J. Million Veteran Program. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat. Genet. 2018 50 10 1412 1425 10.1038/s41588‑018‑0205‑x 30224653
    [Google Scholar]
  7. Giri A. Hellwege J.N. Keaton J.M. Park J. Qiu C. Warren H.R. Torstenson E.S. Kovesdy C.P. Sun Y.V. Wilson O.D. Robinson-Cohen C. Roumie C.L. Chung C.P. Birdwell K.A. Damrauer S.M. DuVall S.L. Klarin D. Cho K. Wang Y. Evangelou E. Cabrera C.P. Wain L.V. Shrestha R. Mautz B.S. Akwo E.A. Sargurupremraj M. Debette S. Boehnke M. Scott L.J. Luan J. Zhao J.H. Willems S.M. Thériault S. Shah N. Oldmeadow C. Almgren P. Li-Gao R. Verweij N. Boutin T.S. Mangino M. Ntalla I. Feofanova E. Surendran P. Cook J.P. Karthikeyan S. Lahrouchi N. Liu C. Sepúlveda N. Richardson T.G. Kraja A. Amouyel P. Farrall M. Poulter N.R. Laakso M. Zeggini E. Sever P. Scott R.A. Langenberg C. Wareham N.J. Conen D. Palmer C.N.A. Attia J. Chasman D.I. Ridker P.M. Melander O. Mook-Kanamori D.O. Harst P. Cucca F. Schlessinger D. Hayward C. Spector T.D. Jarvelin M.R. Hennig B.J. Timpson N.J. Wei W.Q. Smith J.C. Xu Y. Matheny M.E. Siew E.E. Lindgren C. Herzig K.H. Dedoussis G. Denny J.C. Psaty B.M. Howson J.M.M. Munroe P.B. Newton-Cheh C. Caulfield M.J. Elliott P. Gaziano J.M. Concato J. Wilson P.W.F. Tsao P.S. Velez Edwards D.R. Susztak K. O’Donnell C.J. Hung A.M. Edwards T.L. Understanding Society Scientific Group; International Consortium for Blood Pressure; Blood Pressure-International Consortium of Exome Chip Studies; Million Veteran Program. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat. Genet. 2019 51 1 51 62 10.1038/s41588‑018‑0303‑9 30578418
    [Google Scholar]
  8. Padmanabhan S. Joe B. Towards precision medicine for hypertension: A review of genomic, epigenomic, and microbiomic effects on blood pressure in experimental rat models and humans. Physiol. Rev. 2017 97 4 1469 1528 10.1152/physrev.00035.2016 28931564
    [Google Scholar]
  9. Emdin C.A. Khera A.V. Kathiresan S. Mendelian randomization. JAMA 2017 318 19 1925 1926 10.1001/jama.2017.17219 29164242
    [Google Scholar]
  10. Tao Y. Zhao R. Yang B. Han J. Li Y. Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia. J. Transl. Med. 2024 22 1 373 10.1186/s12967‑024‑05153‑3 38637810
    [Google Scholar]
  11. Zheng J. Baird D. Borges M.C. Bowden J. Hemani G. Haycock P. Evans D.M. Smith G.D. Recent developments in mendelian randomization studies. Curr. Epidemiol. Rep. 2017 4 4 330 345 10.1007/s40471‑017‑0128‑6 29226067
    [Google Scholar]
  12. Yuan M. He J. Hu X. Yao L. Chen P. Wang Z. Liu P. Xiong Z. Jiang Y. Li L. Hypertension and NAFLD risk: Insights from the NHANES 2017–2018 and Mendelian randomization analyses. Chin. Med. J. (Engl.) 2024 137 4 457 464 10.1097/CM9.0000000000002753 37455323
    [Google Scholar]
  13. Zhang F. Yu Z. Mendelian randomization study on insulin resistance and risk of hypertension and cardiovascular disease. Sci. Rep. 2024 14 1 6191 10.1038/s41598‑023‑46983‑3 38485964
    [Google Scholar]
  14. Jia T. Liu T. Hu S. Li Y. Chen P. Qin F. He Y. Han F. Zhang C. Uncovering novel drug targets for bipolar disorder: A Mendelian randomization analysis of brain, cerebrospinal fluid, and plasma proteomes. Psychol. Med. 2024 54 11 2996 3006 10.1017/S0033291724001077 38720515
    [Google Scholar]
  15. Gu X.J. Su W.M. Dou M. Jiang Z. Duan Q.Q. Yin K.F. Cao B. Wang Y. Li G.B. Chen Y.P. Expanding causal genes for Parkinson’s disease via multi-omics analysis. NPJ Parkinsons Dis. 2023 9 1 146 10.1038/s41531‑023‑00591‑0 37865667
    [Google Scholar]
  16. Yin K.F. Chen T. Gu X.J. Su W.M. Jiang Z. Lu S.J. Cao B. Chi L.Y. Gao X. Chen Y.P. Systematic druggable genome‐wide mendelian randomization identifies therapeutic targets for sarcopenia. J. Cachexia Sarcopenia Muscle 2024 15 4 1324 1334 10.1002/jcsm.13479 38644354
    [Google Scholar]
  17. Chick J.M. Munger S.C. Simecek P. Huttlin E.L. Choi K. Gatti D.M. Raghupathy N. Svenson K.L. Churchill G.A. Gygi S.P. Defining the consequences of genetic variation on a proteome-wide scale. Nature 2016 534 7608 500 505 10.1038/nature18270 27309819
    [Google Scholar]
  18. Lin J. Zhou J. Xu Y. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. Brain 2023 146 8 3364 3372 10.1093/brain/awad070 36864689
    [Google Scholar]
  19. Ferkingstad E. Sulem P. Atlason B.A. Sveinbjornsson G. Magnusson M.I. Styrmisdottir E.L. Gunnarsdottir K. Helgason A. Oddsson A. Halldorsson B.V. Jensson B.O. Zink F. Halldorsson G.H. Masson G. Arnadottir G.A. Katrinardottir H. Juliusson K. Magnusson M.K. Magnusson O.T. Fridriksdottir R. Saevarsdottir S. Gudjonsson S.A. Stacey S.N. Rognvaldsson S. Eiriksdottir T. Olafsdottir T.A. Steinthorsdottir V. Tragante V. Ulfarsson M.O. Stefansson H. Jonsdottir I. Holm H. Rafnar T. Melsted P. Saemundsdottir J. Norddahl G.L. Lund S.H. Gudbjartsson D.F. Thorsteinsdottir U. Stefansson K. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 2021 53 12 1712 1721 10.1038/s41588‑021‑00978‑w 34857953
    [Google Scholar]
  20. Burgess S. Dudbridge F. Thompson S.G. Combining information on multiple instrumental variables in mendelian randomization: Comparison of allele score and summarized data methods. Stat. Med. 2016 35 11 1880 1906 10.1002/sim.6835 26661904
    [Google Scholar]
  21. Arvanitis M. Tayeb K. Strober B.J. Battle A. Redefining tissue specificity of genetic regulation of gene expression in the presence of allelic heterogeneity. Am. J. Hum. Genet. 2022 109 2 223 239 10.1016/j.ajhg.2022.01.002 35085493
    [Google Scholar]
  22. Liu J. Pan R. Multi-omics association study integrating GWAS and pQTL data revealed MIP-1α as a potential drug target for erectile dysfunction. Front. Pharmacol. 2024 15 1495970 10.3389/fphar.2024.1495970 39555095
    [Google Scholar]
  23. Qiao J. Zhang M. Wang T. Huang S. Zeng P. Evaluating causal relationship between metabolites and six cardiovascular diseases Based on GWAS summary statistics. Front. Genet. 2021 12 746677 10.3389/fgene.2021.746677 34721534
    [Google Scholar]
  24. Siedlinski M. Jozefczuk E. Xu X. Teumer A. Evangelou E. Schnabel R.B. Welsh P. Maffia P. Erdmann J. Tomaszewski M. Caulfield M.J. Sattar N. Holmes M.V. Guzik T.J. White blood cells and blood pressure. Circulation 2020 141 16 1307 1317 10.1161/CIRCULATIONAHA.119.045102 32148083
    [Google Scholar]
  25. Maleki S. Razavi S.H. Pulses’ germination and fermentation: Two bioprocessing against hypertension by releasing ACE inhibitory peptides. Crit. Rev. Food Sci. Nutr. 2021 61 17 2876 2893 10.1080/10408398.2020.1789551 32662284
    [Google Scholar]
  26. Martin M. Deussen A. Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension. Crit. Rev. Food Sci. Nutr. 2019 59 8 1264 1283 10.1080/10408398.2017.1402750 29244531
    [Google Scholar]
  27. Le D. Brown L. Malik K. Murakami S. Two opposing functions of angiotensin-converting enzyme (ACE) that links hypertension, dementia, and aging. Int. J. Mol. Sci. 2021 22 24 13178 10.3390/ijms222413178 34947975
    [Google Scholar]
  28. Exner D.V. Dries D.L. Domanski M.J. Cohn J.N. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N. Engl. J. Med. 2001 344 18 1351 1357 10.1056/NEJM200105033441802 11333991
    [Google Scholar]
  29. Puchalska P. Marina Alegre M.L. García López M.C. Isolation and characterization of peptides with antihypertensive activity in foodstuffs. Crit. Rev. Food Sci. Nutr. 2015 55 4 521 551 10.1080/10408398.2012.664829 24915368
    [Google Scholar]
  30. Zhang X. Wang Y. Zheng Y. Yuan J. Tong J. Xu J. Li Q. Li P. Jiang S. Wang Z. Chai F. Li X. Effect of ACE, ACE2 and CYP11B2 gene polymorphisms and noise on essential hypertension among steelworkers in china: a case–control study. BMC Med. Genomics 2022 15 1 22 10.1186/s12920‑022‑01177‑0 35130889
    [Google Scholar]
  31. Abdelsattar S. Kasemy Z.A. Ewida S.F. Abo-Elsoud R.A.A. Zytoon A.A. Abdelaal G.A. Abdelgawad A.S. Khalil F.O. Kamel H.F.M. ACE2 and TMPRSS2 SNPs as determinants of susceptibility to, and severity of, a COVID-19 infection. Br. J. Biomed. Sci. 2022 79 10238 10.3389/bjbs.2021.10238 35996506
    [Google Scholar]
  32. Vasudeva K. Balyan R. Munshi A. ACE-Triggered hypertension incites stroke: Genetic, molecular, and therapeutic aspects. Neuromolecular Med. 2020 22 2 194 209 10.1007/s12017‑019‑08583‑1 31802381
    [Google Scholar]
  33. Ye D. Cruz-López E.O. Tu H.C. Zlatev I. Danser A.H.J. Targeting angiotensinogen with n -acetylgalactosamine–conjugated small interfering RNA to reduce blood pressure. Arterioscler. Thromb. Vasc. Biol. 2023 43 12 2256 2264 10.1161/ATVBAHA.123.319897 37855126
    [Google Scholar]
  34. Navar L G Translational studies on augmentation of intratubular renin-angiotensin system in hypertension. Kidney Int. Suppl (2011) 2013 3 4 321 325 10.1038/kisup.2013.67 25019012
    [Google Scholar]
  35. Massiéra F. Bloch-Faure M. Ceiler D. Murakami K. Fukamizu A. Gasc J.M. Quignard-Boulangé A. Negrel R. Ailhaud G. Seydoux J. Meneton P. Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001 15 14 1 25 10.1096/fj.01‑0457fje 11606482
    [Google Scholar]
  36. Kalupahana N.S. Massiera F. Quignard-Boulange A. Ailhaud G. Voy B.H. Wasserman D.H. Moustaid-Moussa N. Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity (Silver Spring) 2012 20 1 48 56 10.1038/oby.2011.299 21979391
    [Google Scholar]
  37. Yasue S. Masuzaki H. Okada S. Ishii T. Kozuka C. Tanaka T. Fujikura J. Ebihara K. Hosoda K. Katsurada A. Ohashi N. Urushihara M. Kobori H. Morimoto N. Kawazoe T. Naitoh M. Okada M. Sakaue H. Suzuki S. Nakao K. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: Impact of nutritional status and adipocyte hypertrophy. Am. J. Hypertens. 2010 23 4 425 431 10.1038/ajh.2009.263 20057360
    [Google Scholar]
  38. Gu H. Ma Z. Wang J. Zhu T. Du N. Shatara A. Yi X. Kowala M.C. Du Y. Salt-dependent blood pressure in human aldosterone synthase-transgenic mice. Sci. Rep. 2017 7 1 492 10.1038/s41598‑017‑00461‑9 28352088
    [Google Scholar]
  39. Pellieux C. Montessuit C. Papageorgiou I. Pedrazzini T. Lerch R. Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice. Am. J. Physiol. Heart Circ. Physiol. 2012 302 9 H1795 H1805 10.1152/ajpheart.01023.2011 22408021
    [Google Scholar]
  40. Takeda Y. Zhu A. Yoneda T. Usukura M. Takata H. Yamagishi M. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in dahl salt-sensitive hypertensive rats. Am. J. Hypertens. 2007 20 10 1119 1124 10.1016/j.amjhyper.2007.05.008 17903697
    [Google Scholar]
  41. Mullick A.E. Yeh S.T. Graham M.J. Engelhardt J.A. Prakash T.P. Crooke R.M. Blood pressure lowering and safety improvements with liver angiotensinogen inhibition in models of hypertension and kidney injury. Hypertension 2017 70 3 566 576 10.1161/HYPERTENSIONAHA.117.09755 28716988
    [Google Scholar]
  42. Uijl E. Ye D. Ren L. Mirabito Colafella K.M. van Veghel R. Garrelds I.M. Lu H.S. Daugherty A. Hoorn E.J. Nioi P. Foster D. Danser A.H.J. Conventional vasopressor and vasopressor‐sparing strategies to counteract the blood pressure–lowering effect of small interfering rna targeting angiotensinogen. J. Am. Heart Assoc. 2022 11 15 e026426 10.1161/JAHA.122.026426 35876413
    [Google Scholar]
  43. Nair J.K. Willoughby J.L.S. Chan A. Charisse K. Alam M.R. Wang Q. Hoekstra M. Kandasamy P. Kel’in A.V. Milstein S. Taneja N. O’Shea J. Shaikh S. Zhang L. van der Sluis R.J. Jung M.E. Akinc A. Hutabarat R. Kuchimanchi S. Fitzgerald K. Zimmermann T. van Berkel T.J.C. Maier M.A. Rajeev K.G. Manoharan M. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc. 2014 136 49 16958 16961 10.1021/ja505986a 25434769
    [Google Scholar]
  44. Springer A.D. Dowdy S.F. GalNAc-siRNA Conjugates: Leading the way for delivery of RNAi therapeutics. Nucleic Acid Ther. 2018 28 3 109 118 10.1089/nat.2018.0736 29792572
    [Google Scholar]
  45. Bovée D.M. Ren L. Uijl E. Clahsen-van Groningen M.C. van Veghel R. Garrelds I.M. Domenig O. Poglitsch M. Zlatev I. Kim J.B. Huang S. Melton L. Lu X. Hoorn E.J. Foster D. Danser A.H.J. Renoprotective effects of small interfering RNA Targeting liver angiotensinogen in experimental chronic kidney disease. Hypertension 2021 77 5 1600 1612 10.1161/HYPERTENSIONAHA.120.16876 33719507
    [Google Scholar]
  46. Suga S. Nakao K. Hosoda K. Mukoyama M. Ogawa Y. Shirakami G. Arai H. Saito Y. Kambayashi Y. Inouye K. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992 130 1 229 239 10.1210/endo.130.1.1309330 1309330
    [Google Scholar]
  47. Forte M. Marchitti S. Di Nonno F. Stanzione R. Schirone L. Cotugno M. Bianchi F. Schiavon S. Raffa S. Ranieri D. Fioriniello S. Della Ragione F. Torrisi M.R. Carnevale R. Valenti V. Versaci F. Frati G. Vecchione C. Volpe M. Rubattu S. Sciarretta S. NPPA/atrial natriuretic peptide is an extracellular modulator of autophagy in the heart. Autophagy 2023 19 4 1087 1099 10.1080/15548627.2022.2115675 35998113
    [Google Scholar]
  48. Volpe M. Rubattu S. Burnett J. Natriuretic peptides in cardiovascular diseases: Current use and perspectives. Eur. Heart J. 2014 35 7 419 425 10.1093/eurheartj/eht466 24227810
    [Google Scholar]
  49. Ehret G.B. Munroe P.B. Rice K.M. Bochud M. Johnson A.D. Chasman D.I. Smith A.V. Tobin M.D. Verwoert G.C. Hwang S.J. Pihur V. Vollenweider P. O’Reilly P.F. Amin N. Bragg-Gresham J.L. Teumer A. Glazer N.L. Launer L. Zhao J.H. Aulchenko Y. Heath S. Sõber S. Parsa A. Luan J. Arora P. Dehghan A. Zhang F. Lucas G. Hicks A.A. Jackson A.U. Peden J.F. Tanaka T. Wild S.H. Rudan I. Igl W. Milaneschi Y. Parker A.N. Fava C. Chambers J.C. Fox E.R. Kumari M. Go M.J. van der Harst P. Kao W.H. Sjögren M. Vinay D.G. Alexander M. Tabara Y. Shaw-Hawkins S. Whincup P.H. Liu Y. Shi G. Kuusisto J. Tayo B. Seielstad M. Sim X. Nguyen K.D. Lehtimäki T. Matullo G. Wu Y. Gaunt T.R. Onland-Moret N.C. Cooper M.N. Platou C.G. Org E. Hardy R. Dahgam S. Palmen J. Vitart V. Braund P.S. Kuznetsova T. Uiterwaal C.S. Adeyemo A. Palmas W. Campbell H. Ludwig B. Tomaszewski M. Tzoulaki I. Palmer N.D. Aspelund T. Garcia M. Chang Y.P. O’Connell J.R. Steinle N.I. Grobbee D.E. Arking D.E. Kardia S.L. Morrison A.C. Hernandez D. Najjar S. McArdle W.L. Hadley D. Brown M.J. Connell J.M. Hingorani A.D. Day I.N. Lawlor D.A. Beilby J.P. Lawrence R.W. Clarke R. Hopewell J.C. Ongen H. Dreisbach A.W. Li Y. Young J.H. Bis J.C. Kähönen M. Viikari J. Adair L.S. Lee N.R. Chen M.H. Olden M. Pattaro C. Bolton J.A. Köttgen A. Bergmann S. Mooser V. Chaturvedi N. Frayling T.M. Islam M. Jafar T.H. Erdmann J. Kulkarni S.R. Bornstein S.R. Grässler J. Groop L. Voight B.F. Kettunen J. Howard P. Taylor A. Guarrera S. Ricceri F. Emilsson V. Plump A. Barroso I. Khaw K.T. Weder A.B. Hunt S.C. Sun Y.V. Bergman R.N. Collins F.S. Bonnycastle L.L. Scott L.J. Stringham H.M. Peltonen L. Perola M. Vartiainen E. Brand S.M. Staessen J.A. Wang T.J. Burton P.R. Soler Artigas M. Dong Y. Snieder H. Wang X. Zhu H. Lohman K.K. Rudock M.E. Heckbert S.R. Smith N.L. Wiggins K.L. Doumatey A. Shriner D. Veldre G. Viigimaa M. Kinra S. Prabhakaran D. Tripathy V. Langefeld C.D. Rosengren A. Thelle D.S. Corsi A.M. Singleton A. Forrester T. Hilton G. McKenzie C.A. Salako T. Iwai N. Kita Y. Ogihara T. Ohkubo T. Okamura T. Ueshima H. Umemura S. Eyheramendy S. Meitinger T. Wichmann H.E. Cho Y.S. Kim H.L. Lee J.Y. Scott J. Sehmi J.S. Zhang W. Hedblad B. Nilsson P. Smith G.D. Wong A. Narisu N. Stančáková A. Raffel L.J. Yao J. Kathiresan S. O’Donnell C.J. Schwartz S.M. Ikram M.A. Longstreth W.T. Mosley T.H. Seshadri S. Shrine N.R. Wain L.V. Morken M.A. Swift A.J. Laitinen J. Prokopenko I. Zitting P. Cooper J.A. Humphries S.E. Danesh J. Rasheed A. Goel A. Hamsten A. Watkins H. Bakker S.J. van Gilst W.H. Janipalli C.S. Mani K.R. Yajnik C.S. Hofman A. Mattace-Raso F.U. Oostra B.A. Demirkan A. Isaacs A. Rivadeneira F. Lakatta E.G. Orru M. Scuteri A. Ala-Korpela M. Kangas A.J. Lyytikäinen L.P. Soininen P. Tukiainen T. Würtz P. Ong R.T. Dörr M. Kroemer H.K. Völker U. Völzke H. Galan P. Hercberg S. Lathrop M. Zelenika D. Deloukas P. Mangino M. Spector T.D. Zhai G. Meschia J.F. Nalls M.A. Sharma P. Terzic J. Kumar M.V. Denniff M. Zukowska-Szczechowska E. Wagenknecht L.E. Fowkes F.G. Charchar F.J. Schwarz P.E. Hayward C. Guo X. Rotimi C. Bots M.L. Brand E. Samani N.J. Polasek O. Talmud P.J. Nyberg F. Kuh D. Laan M. Hveem K. Palmer L.J. van der Schouw Y.T. Casas J.P. Mohlke K.L. Vineis P. Raitakari O. Ganesh S.K. Wong T.Y. Tai E.S. Cooper R.S. Laakso M. Rao D.C. Harris T.B. Morris R.W. Dominiczak A.F. Kivimaki M. Marmot M.G. Miki T. Saleheen D. Chandak G.R. Coresh J. Navis G. Salomaa V. Han B.G. Zhu X. Kooner J.S. Melander O. Ridker P.M. Bandinelli S. Gyllensten U.B. Wright A.F. Wilson J.F. Ferrucci L. Farrall M. Tuomilehto J. Pramstaller P.P. Elosua R. Soranzo N. Sijbrands E.J. Altshuler D. Loos R.J. Shuldiner A.R. Gieger C. Meneton P. Uitterlinden A.G. Wareham N.J. Gudnason V. Rotter J.I. Rettig R. Uda M. Strachan D.P. Witteman J.C. Hartikainen A.L. Beckmann J.S. Boerwinkle E. Vasan R.S. Boehnke M. Larson M.G. Järvelin M.R. Psaty B.M. Abecasis G.R. Chakravarti A. Elliott P. van Duijn C.M. Newton-Cheh C. Levy D. Caulfield M.J. Johnson T. International Consortium for Blood Pressure Genome-Wide Association Studies; CARDIoGRAM consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen consortium; CHARGE-HF consortium. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011 478 7367 103 109 10.1038/nature10405 21909115
    [Google Scholar]
  50. Newton-Cheh C. Larson M.G. Vasan R.S. Levy D. Bloch K.D. Surti A. Guiducci C. Kathiresan S. Benjamin E.J. Struck J. Morgenthaler N.G. Bergmann A. Blankenberg S. Kee F. Nilsson P. Yin X. Peltonen L. Vartiainen E. Salomaa V. Hirschhorn J.N. Melander O. Wang T.J. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat. Genet. 2009 41 3 348 353 10.1038/ng.328 19219041
    [Google Scholar]
  51. Kato N. Takeuchi F. Tabara Y. Kelly T.N. Go M.J. Sim X. Tay W.T. Chen C.H. Zhang Y. Yamamoto K. Katsuya T. Yokota M. Kim Y.J. Ong R.T.H. Nabika T. Gu D. Chang L. Kokubo Y. Huang W. Ohnaka K. Yamori Y. Nakashima E. Jaquish C.E. Lee J.Y. Seielstad M. Isono M. Hixson J.E. Chen Y.T. Miki T. Zhou X. Sugiyama T. Jeon J.P. Liu J.J. Takayanagi R. Kim S.S. Aung T. Sung Y.J. Zhang X. Wong T.Y. Han B.G. Kobayashi S. Ogihara T. Zhu D. Iwai N. Wu J.Y. Teo Y.Y. Tai E.S. Cho Y.S. He J. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east asians. Nat. Genet. 2011 43 6 531 538 10.1038/ng.834 21572416
    [Google Scholar]
  52. Arora P. Wu C. Khan A.M. Bloch D.B. Davis-Dusenbery B.N. Ghorbani A. Spagnolli E. Martinez A. Ryan A. Tainsh L.T. Kim S. Rong J. Huan T. Freedman J.E. Levy D. Miller K.K. Hata A. del Monte F. Vandenwijngaert S. Swinnen M. Janssens S. Holmes T.M. Buys E.S. Bloch K.D. Newton-Cheh C. Wang T.J. Atrial natriuretic peptide is negatively regulated by microRNA-425. J. Clin. Invest. 2013 123 8 3378 3382 10.1172/JCI67383 23867623
    [Google Scholar]
  53. Arora P. Wu C. Hamid T. Arora G. Agha O. Allen K. Tainsh R.E.T. Hu D. Ryan R.A. Domian I.J. Buys E.S. Bloch D.B. Prabhu S.D. Bloch K.D. Newton-Cheh C. Wang T.J. Acute metabolic influences on the natriuretic peptide system in humans. J. Am. Coll. Cardiol. 2016 67 7 804 812 10.1016/j.jacc.2015.11.049 26892417
    [Google Scholar]
  54. Wu C. Arora P. Agha O. Hurst L.A. Allen K. Nathan D.I. Hu D. Jiramongkolchai P. Smith J.G. Melander O. Trenson S. Janssens S.P. Domian I. Wang T.J. Bloch K.D. Buys E.S. Bloch D.B. Newton-Cheh C. Novel MicroRNA regulators of atrial natriuretic peptide production. Mol. Cell. Biol. 2016 36 14 1977 1987 10.1128/MCB.01114‑15 27185878
    [Google Scholar]
  55. Ruilope L.M. Dukat A. Böhm M. Lacourcière Y. Gong J. Lefkowitz M.P. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: A randomised, double-blind, placebo-controlled, active comparator study. Lancet 2010 375 9722 1255 1266 10.1016/S0140‑6736(09)61966‑8 20236700
    [Google Scholar]
/content/journals/cad/10.2174/0115734099382081251126112854
Loading
/content/journals/cad/10.2174/0115734099382081251126112854
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: genomic targets ; drug target ; plasma proteome ; Hypertension ; mendelian randomization ; pQTL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test